Viral Hepatitis B and C in Children

Bellentani S. , Pozzato G. , Saccoccio G. Clinical course and risk factors of hepatitis C virus related liver disease in the general population: report from the Dionysos study. Gut 1999; 44: 874–80

Chu C.M. Natural history of chronic hepatitis B virus infection in adults: emphasis on the occurrence of cirrhosis and hepatocellular carcinoma. J Gastroenterol Hepatotol 2000; 15(suppl): E25–30

Lee W.S. , McKiernan P. , Kelly D.A. Etiology, outcome and prognostic indicators of childhood fulminant hepatic failure in the United Kingdom. J Paediat Gastroenterol Nutr 2005; 40: 575–81

Chang M.H. Viral mutants and fulminant hepatitis. A dominant hepatitis B virus population defective in virus secretion because of several S-gene mutations from a patient with fulminant hepatitis. J Pediat Gastroenterol Nutr 2002; 34: 426

Bramley J.C. , Wallace L.A. , Ahmed S. . Universal hepatitis B vaccination of UK adolescents: a feasibility and acceptability study. Commun Dis Publ Health 2002; 5: 318–20

Boxall E.H. , Sira J. , El-Shukri N. , Kelly D.A. Long-term persistence of immunity to hepatitis B after vaccination during infancy in a country where endemicity is low. J Infect Dis 2004; 190: 1264–9

Petersen K.M. , Bulkow L.R. , McMahon M.D. . Duration of hepatitis B immunity in low risk children receiving hepatitis B vaccinations from birth. Pediatr Infect Dis J 2004; 23: 650–5

Chang M.H. , Chen C.J. , Lai M.S. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N Engl J Med 1997; 336: 1855–5

Boxall E.H. , Sira J. , Standish R.A. . Natural history of hepatitis B in perinatally infected carriers. Arch Dis Child Fetal Neonatal Ed 2004; 89: 456–60

Bortolotti F. , Jara P. , Crivello C. . Outcome of chronic hepatitis B in Caucasian children during a 20-year observation period. J Hepatol 1998; 29: 184–90

Moore S.W. , Millar A.J. , Hadley G.P. . Hepatocellular carcinoma and liver tumors in South African children: a case for increased prevalence. Cancer 2004; 101: 642–9

Jara P. , Bortolotti F. Interferon-α treatment of chronic hepatitis B in childhood: a consensus advice based on experience in European children. J Pediat Gastroenterol Nutr 1999; 29: 163–70

Bortolotti F. , Jara P. , Barbera C. . Long term affect of alpha interferon in children with chronic hepatitis B. Gut 2000; 46: 715–18

Krogsgaard K. , Marcellin P. , Trepo C. Prednisolone withdrawal therapy enhances the effect of human lymphoblastoid interferon in chronic hepatitis B. INTERPRED Trial Group. J Hepatol 1996; 25: 803–13

Jonas M. , Kelly D. , Mizerski J. Clinical trial of Lamivudine in children with chronic hepatitis B. N Engl J Med 2002; 346: 1706–13

Sokal E. Drug treatment of pediatric chronic hepatitis B. Paediatr Drugs 2002; 4: 361–9

Marcellin P. , Chang T.T. , Lim S.G. . Adefovir Dipivoxil for the treatment of hepatitis Be antigen-positive chronic hepatitis B. N Engl J Med 2003; 348: 808–16

Hadziyannis S. , Tassopoulos N.C. , Heathcote E.J. . for the Adefovir Dipivoxil 438 Study Group. Long-term therapy with Adefovir Dipivoxil 438 Study Group. N Engl J Med 2005; 352: 2673–81

Terrault N.A. Treatment of recurrent hepatitis B infection in liver transplant recipients. Liver Transpl 2002; 8(suppl 1): S74–81

Curry M.P. Hepatitis B and hepatitis C viruses in liver transplantation. Transplantation 2004; 78: 955–63

Lau G.K.K. , Piratvisuth T. , Luo K.X. . for the Peginterferon Alfa-2A HBeAG-Positive Chronic Hepatitis B Study Group. Peginterferon alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B. N Engl J Med 2005; 352: 2682–95

Choo Q.L. , Kuo G. , Weiner AJ , Overby LR , Bradley D.W. Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A non-B viral hepatitis genome. Science 1989; 224: 359–62

Honda M. , Kaneko S. , Sakai A. Degree of diversity of hepatitis C virus quasispecies and progression of liver disease. Hepatology 1994; 20: 1141–51

Bunn S.K. , Sire J. , Brown R. , Kelly D.A. Hepatitis C: a single UK centre experience. Arch Dis Childh 2006; 91(Suppl): A16

Gibb D.M. , Neave P. , Tookey P.A. . Active surveillance of hepatitis C infection in the UK and Ireland. Arch Dis Childh 2000; 82: 286–92

Thomas S.L. , Newell M.L. , Peckham C.S. , Ades A.F. , Hall A.J. A review of hepatitis C virus (HCV) vertical transmission: risks of transmission to infants born to mothers with and without HCV viraemia or human immunodeficiency virus infection. Int J Epidemol 1998; 27: 108–17

Resti M. , Azzari C. , Mannelli F. , Tuscany Study Group on hepatitis C infection in children. Mother to child transmission of hepatitis C virus: prospective study of risk factors and timing of infection in children born to women seronegative for HIV-1. BMJ 1998; 317: 437–41

Resti M. , Bortolotti F. , Vajro P. , Maggiore G. , Committee of Hepatology of the Italian Society of Pediatric Gastroenterology and Hepatology. Guidelines for the screening and follow-up of infants born to anti-HCV positive mothers. Dig Liver Dis 2003; 35: 453–7

Ruiz-Extremera A. , Salmeron J. , Torres C. Follow-up of transmission of hepatitis C to babies of human immunodeficiency virus-negative women: the role of breast-feeding in transmission. Pediat Infect Dis J 2000; 19: 511–16

European Paediatric Hepatitis C Virus Network. Effects of mode of delivery and infant feeding on the risk of mother-to-child transmission of hepatitis C virus. Br J Obstet Gynaecol 2001; 108: 371–7

Roberts E.A. , King S.M. , Fearon M. , McGee N. Hepatitis C in children after transfusion: assessment by look-back studies. Acta Gastroenterol Belg 1998; 61: 195–7

Vogt M. , Lang T. , Frosner G. Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood donor screening. N Engl J Med 1999; 341: 866–70

Tovo P.A. , Pembrey L.J. , Newell M.L. Persistence rate and progression of vertically acquired hepatitis C infection. European paediatric hepatitis C virus infection. J Infect Dis 2000; 181: 419–24

Orland J.R. , Wright T.L. , Cooper S. Acute hepatitis C. Hepatology 2001; 33: 321–7

Badizadegan K. , Jonas M. , Ott M.J. Histopathology of the liver in children with chronic hepatitis C viral infection. Hepatology 1998; 28: 1416–23

Gonzalez-Peralta R.P. , Kelly D.A. , Haber B. . Interferon alfa-2b ribavirin for children with chronic hepatitis C: efficacy, safety and pharmacokinetics. Hepatology 2005; 42: 1010–18

Wirth S. , Pieper-Boustani H. , Lang T. . Peginterferon alfa-2b plus ribavirin treatment in children and adolescents with chronic hepatitis B. Hepatology 2005; 41: 1013–18